Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06804655
What this trial is testing

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Who this might be right for
Brain (Nervous System) CancersGlioblastomaGlioma+5 more
University of Zurich 40
Early research (Phase 1)UnknownNCT01972750
What this trial is testing

Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma

Who this might be right for
First or Second Recurrence of Glioblastoma
PD Dr. Martin Glas 12
Testing effectiveness (Phase 2)Study completedNCT04740190
What this trial is testing

Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd

Who this might be right for
Recurrent GliomaRecurrent GlioblastomaPoly ADP Ribose Polymerase (PARP) Inhibitor+2 more
The University of Hong Kong 33
Early research (Phase 1)Enrolling By InvitationNCT06896110
What this trial is testing

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

Who this might be right for
Glioblastoma (GBM)Diffuse Midline Glioma (DMG)Astrocytoma, IDH-Mutant, Grade 4+2 more
Andrew P. Groves 34
Testing effectiveness (Phase 2)Looking for participantsNCT07501559
What this trial is testing

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

Who this might be right for
Recurrent Glioblastoma Multiforme(GBM)
Jecho Biopharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT01081223
What this trial is testing

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Who this might be right for
GliomaHigh Grade AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 12
Testing effectiveness (Phase 2)Study completedNCT00431561
What this trial is testing

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Isarna Therapeutics GmbH 141
Testing effectiveness (Phase 2)Study completedNCT00606008
What this trial is testing

A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma

Who this might be right for
Anaplastic AstrocytomaGlioblastoma
H. Lee Moffitt Cancer Center and Research Institute 30
Early research (Phase 1)Ended earlyNCT04397679
What this trial is testing

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Barbara Ann Karmanos Cancer Institute 2
Not applicableTemporarily pausedNCT05695976
What this trial is testing

GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM

Who this might be right for
GlioblastomaGlioma, Malignant
Duke University 100
Testing effectiveness (Phase 2)WithdrawnNCT02876003
What this trial is testing

Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma

Who this might be right for
Glioblastoma
GenSpera, Inc.
Early research (Phase 1)Active Not RecruitingNCT02192359
What this trial is testing

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Recurrent Anaplastic AstrocytomaRecurrent Anaplastic OligoastrocytomaRecurrent Anaplastic Oligodendroglioma+4 more
City of Hope Medical Center 18
Early research (Phase 1)Active Not RecruitingNCT02381886
What this trial is testing

IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

Who this might be right for
Advanced Malignancies That Harbor IDHR132 Mutations
Novartis Pharmaceuticals 166
Testing effectiveness (Phase 2)Study completedNCT00354913
What this trial is testing

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

Who this might be right for
GlioblastomaGliosarcoma
Duke University 21
Testing effectiveness (Phase 2)Ended earlyNCT01433991
What this trial is testing

E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

Who this might be right for
Advanced Solid Tumors
Eisai Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00082797
What this trial is testing

High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 36
Testing effectiveness (Phase 2)UnknownNCT04614493
What this trial is testing

Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.

Who this might be right for
Initial Radiological Diagnosis Eligible for Tumor ResectionInitial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide
Assistance Publique - Hôpitaux de Paris 66
Testing effectiveness (Phase 2)Study completedNCT00409214
What this trial is testing

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Who this might be right for
GliomaGlioblastoma MultiformeAnaplastic Astrocytoma
Light Sciences Oncology 18
Testing effectiveness (Phase 2)Ended earlyNCT05370508
What this trial is testing

Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM

Who this might be right for
Recurrent GBM
SonALAsense, Inc. 8
Testing effectiveness (Phase 2)UnknownNCT01124240
What this trial is testing

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene

Who this might be right for
Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4
Northern Sydney and Central Coast Area Health Service 48
Next Page